Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal dexmedetomidine vs fentanyl vs magnesium sulfate as adjuvants to ropivacaine in lower abdominal surgery
IRCT20141209020258N118Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Mar 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ropivacaine, dexmedetomidine, fentanyl and magnesium sulfate in None (3 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Blood pressure, Heart rate and 7 more. Started Mar 2019; status: completed.
02
Drugs
ropivacainedexmedetomidinefentanylmagnesium sulfate
Beyond the preview
Go deeper on IRCT20141209020258N118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N118.